Literature DB >> 1531378

Estimation of renal tubular secretion in man, in health and disease, using endogenous N-1-methylnicotinamide.

A Maïza1, S Waldek, F W Ballardie, P T Daley-Yates.   

Abstract

We have been investigating the possibility of using the renal clearance of endogenous N-1-methylnicotinamide (NMN) as a marker of renal tubular function. Sixty-three subjects (11 healthy volunteers and 52 patients with renal impairment) were used for this study. The subjects were divided into three groups according to their creatinine clearance: group 1, over 80 ml/min; group 2, between 30 and 80 ml/min, and group 3, less than 30 ml/min. The correlation between NMN and creatinine clearance was compared for each group. A good correlation (r = 0.84) was found for groups 1 and 3 (r = 0.76), whereas for group 2, a poor correlation was found (r = 0.43). For subjects with mild renal impairment (group 2), there was clear evidence of glomerulo-tubular imbalance manifest by a larger variability in NMN clearance than creatinine clearance and an essentially non-parallel decline in these two parameters for this group. When all subjects were grouped together, the relationship between the clearance of NMN and of creatinine was best described by a 3-term polynomial equation (r = 0.93). NMN clearance is a potentially useful non-invasive marker of renal tubular function in man and provides additional information to that provided by the measurement of creatinine clearance alone. This substance should be more fully evaluated as a potential diagnostic aid.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531378     DOI: 10.1159/000186698

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  11 in total

Review 1.  Measurement of renal function during drug development.

Authors:  D Craig Brater
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 2.  Principles of drug administration in renal insufficiency.

Authors:  Y W Lam; S Banerji; C Hatfield; R L Talbert
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

3.  Pregnancy Increases the Renal Secretion of N1-methylnicotinamide, an Endogenous Probe for Renal Cation Transporters, in Patients Prescribed Metformin.

Authors:  Mackenzie C Bergagnini-Kolev; Mary F Hebert; Thomas R Easterling; Yvonne S Lin
Journal:  Drug Metab Dispos       Date:  2017-01-09       Impact factor: 3.922

4.  Effect of dronedarone on renal function in healthy subjects.

Authors:  Yvonne Tschuppert; Thierry Buclin; Laura E Rothuizen; Laurent A Decosterd; Jacques Galleyrand; Christine Gaud; Jérôme Biollaz
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

5.  Variability in the renal clearance of cephalexin in experimental renal failure.

Authors:  A Maïza; P T Daley-Yates
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

Review 6.  Principles and clinical application of assessing alterations in renal elimination pathways.

Authors:  Susan E Tett; Carl M J Kirkpatrick; Annette S Gross; Andrew J McLachlan
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway.

Authors:  S Chlopicki; J Swies; A Mogielnicki; W Buczko; M Bartus; M Lomnicka; J Adamus; J Gebicki
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

8.  Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients.

Authors:  Ming Liu; Jihong Chu; Yang Gu; Haibo Shi; Rusheng Zhang; Lingzhun Wang; Jiandong Chen; Le Shen; Peng Yu; Xiaohu Chen; Wenzheng Ju; Zhenxing Wang
Journal:  J Am Heart Assoc       Date:  2017-02-07       Impact factor: 5.501

9.  Serum N1-methylnicotinamide is Associated with Left Ventricular Systolic Dysfunction in Chinese.

Authors:  Ming Liu; Anxia He; Jihong Chu; Chao Chen; Siqi Zhang; Yun He; Weiwei Tao; Meijuan Lu; Mulian Hua; Wenzheng Ju; Zhuyuan Fang
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

10.  Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics.

Authors:  Xu Hao; Xia Liu; Weiming Wang; Hong Ren; Jingyuan Xie; Pingyan Shen; Donghai Lin; Nan Chen
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.